Isotrétinoïne Eg

Isotretinoin, the active ingredient in Isotrétinoïne Eg, is a retinoid presented as an oral capsule for oral use. It is prescribed for severe nodular acne and other forms of acne vulgaris in patients who have not responded to conventional therapy.

GNH USA supplies Isotrétinoïne Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Isotretinoin is a systemic retinoid used in the management of severe acne conditions.

Severe nodular acne: markedly reduces inflammatory lesions and prevents new nodule formation. Acne vulgaris (moderate to severe): improves skin clearance and reduces comedones. Recalcitrant acne unresponsive to antibiotics: provides long‑term remission after a course of therapy.

Isotretinoin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Nasal dryness and epistaxis. - Elevated liver enzymes. - Hypertriglyceridemia. - Photosensitivity.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease flare. - Birth defects (teratogenicity). - Pancreatitis. - Severe liver injury. - Pseudotumor cerebri (intracranial hypertension).

Isotretinoin requires careful monitoring and specific safety measures.

Pregnancy contraindication: drug is teratogenic (Category X) and must not be used by pregnant women. Contraception requirement: women of child‑bearing potential must use effective contraception during treatment and for one month after. Liver function monitoring: obtain baseline and periodic liver enzymes. Lipid profile monitoring: check triglycerides and cholesterol regularly. Avoid vitamin A supplements: concurrent use may increase toxicity. Store at ambient temperature: keep in original container, protect from moisture and light.

Isotretinoin interacts with several medicines; some combinations should be avoided while others need close observation.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A or other retinoids: additive teratogenicity and toxicity. - Systemic corticosteroids: may exacerbate pseudotumor cerebri.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may have reduced efficacy; monitor menstrual changes. - Anticoagulants (e.g., warfarin): isotretinoin may potentiate anticoagulant effect; monitor INR. - Enzyme‑inducing antiepileptics (e.g., carbamazepine): may lower isotretinoin plasma levels; adjust therapy as needed.